Fact CheckerSign in

NCT01048281Recruiting

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

Source: ClinicalTrials.gov · Last updated 18 Dec 2025

Brief summary (registry, in English)

Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn the role genes and proteins play in the development of gastric and esophageal cancer.

Status (registry)
Recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
11 Jan 2010
Start date
1 Aug 2002
Primary completion date
31 Jan 2099
Lead sponsor
Stanford University
NCT number
NCT01048281

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 1 Aug 2002 to the primary completion date, 31 Jan 2099
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • No family or personal history of gastric or esophageal cancer

Other

  • Under 18

Who the study is looking for

  • Over 18
  • Diagnosed with gastric or esophageal cancer OR at an increased hereditary risk for upper GI cancer

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Stanford University School of Medicine
Coordinator of this site? Confirm its status
StanfordUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.